Roche Pharma launches drug to treat breast cancer

PHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in December 2020. In India, PHESGO was approved by the DCGI in October 2021 and the import license was granted in January 2022. Globally, over 17,000 breast cancer patients have benefitted from PHESGO as on December 2021, the drug firm stated.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EmbFPQT
via IFTTT